ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In the most relevant study to date of 191 patients with biopsy-proven NAFLD and advanced fibrosis (F3-F4) (119 without and 72 with NAFLD-associated HCC), it was shown that circulating adiponectin was higher in those with than without HCC [68].